Viewing Study NCT05826067



Ignite Creation Date: 2024-05-06 @ 6:54 PM
Last Modification Date: 2024-10-26 @ 2:56 PM
Study NCT ID: NCT05826067
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-04-26
First Post: 2023-04-11

Brief Title: Study of E Coli Isolates From Recurrent Urinary Tract Infections
Sponsor: Université Catholique de Louvain
Organization: Université Catholique de Louvain

Study Overview

Official Title: Systematic Analysis of Bacterial Multidrug Tolerance in Longitudinal Isolates of Patients That Are Prone to Developing Urinary Tract Infections
Status: NOT_YET_RECRUITING
Status Verified Date: 2023-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: Per-UTI
Brief Summary: Prospective study aiming at collecting clinical Escherichia coli isolates from patients with recurrent urinary tract infection samples to be collected during routine procedures
Detailed Description: In a clinical context persisters are of potential concern as they perpetuate chronic infections and enhance the development of antibiotic resistance Novel therapeutic strategies to combat persisters are therefore highly needed Most mechanistic studies on persistence to date deal with lab strains The main goal of this project is to define principles of persistence and its evolution in natural strains of E coli isolated from patients Isolates will be collected as follows from three types of patients corresponding to 3 different clinical situations where recurrent infection is likely

A Patients with urinary tract infection caused by E coli with or without neurological disorders

First visit for patients suspected for UTI a first urine sample is collected as part of the routine diagnosis procedure for this type of infection before starting any antibiotic treatment Likewise a blood sample is taken to establish a possible concomitant sepsis if considered useful by the doctor If the diagnosis of UTI is confirmed informed consent will be obtained after explanation of the study by the investigator making clear that the patient will be included only if E coli is isolated from the urine If the patient agrees to participate the samples will be stored at -80C for further analysis Using a standardized questionnaire a detailed medical history concerning recent UTIs and antibiotics taken by the patients is composed possibly with the help of the family doctor of the patient if heshe does agree

Next visits If the patients come back for another episode at least 2 weeks after the end of the treatment for the previous episode has been resolved or for a control visit data concerning their recent UTI history and antibiotic use will be collected using standardized questionnaires A new urine sample will be collected If the patients consult their GP for a new episode they will be asked to fill the form with their GP and instruct the lab where the analysis of the new sample is done to send the strain to Saint Luc cost will be covered Written instruction will be provided

IMPORTANT The collection of urine samples for this study will not impede SOC Samples are taken following the protocols used for patients with UTIs and sepsis The antibiotic regimen will not be adapted based on these results When signing the informed consent the patients will be informed that they will not personally benefit from the study but help scientific research

B-C Patients that are planned to undergo the insertion of a suprapubic or nephrostomy catheter

Visit 1 These patients are seen at the ward or consultation for a variety of non-UTI related problems During this visit informed consent is obtained and the study is explained by the investigator Using a standardized questionnaire a detailed medical history concerning recent UTIs and antibiotics taken by the patients is composed possibly with the help of the family doctor of the patient if heshe does agree A first urine sample is collected

Visit 2 if not performed in visit 1 Insertion of the catheter and collection of a new urine sample again this is part of standard of care and not a study procedure

Next visits Regular exchange of the catheter every 6 weeks at the urology department During these visits patients are asked about their recent UTI history and any antibiotic use Prior to the exchange a urine sample is taken and the tip of the old catheter is collected as per standard of care Isolates from urine will be frozen and tips of catheter will be processed for biofilm disruption and freezing of bacteria

IMPORTANT The collection of urine samples for this study will not impede SOC Samples are taken following the protocols used for patients with UTIs and sepsis The antibiotic regimen if any will not be adapted based on these results When signing the informed consent the patients will be informed that they will not personally benefit from the study but help scientific research

Patients will be recruited over a two years period For each patient the duration of the participation will correspond A to each episode of UTI with sepsis over that period of time and B-C to the period during which a catheter remains in place over the study period

Directly after collection biofilms on catheter tips will be disrupted following in-house protocols For both urine samples and catheter tip biofilms bacterial strains will be isolated by inoculating on selective agar plates MacConkey mannitol salt cetrimide followed by aerobic incubation at 37C for 24h Bacterial isolates observed on the selective media plates will be aseptically subcultured onto freshly prepared media plates and subjected to identification For patients suffering from recurrent UTIs the investigators expect to find mainly Escherichia coli while for patients with a suprapubic catheter the investigators expect mainly E coli as well as Pseudomonas aeruginosa Proteus mirabilis and Klebsiella pneumoniae strains Only E coli will be stored for the study

Isolates will then be transferred to research lab of the sponsor for further molecular analysis determination of persister character in the presence of antibiotic WGS essentially

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None